Table 2.
The distribution of different phases of MCF-7 cell cycle after 1α,25(OH)2D3 or MART-10 treatment determined by flow cytometry with Annexin V-FITC and PI staining.
| PI negative, Annexin V negative |
PI negative, Annexin V positive |
PI positive, Annexin V positive |
|
|---|---|---|---|
| Control | 76.22% | 1.59% | 7.19% |
| 1α,25(OH)2D3 (10−6 M) | 65.79% | 1.19% | 10.04% |
| MART-10 (10−7 M) |
57.87% | 1.76% | 13.66% |